Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TEVA
$39.53
+0.56%
TEVA
· Teva Pharmaceutical Industries Ltd
Market Cap
$45.67B
Shares
1.17B
Volume · Oct 2
4.77M
Avg daily vol (3M)
5.34M
All webcasts
Earnings call · FY2021 Q2
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$3.91B
+1% YoY
Diluted EPS
$0.19
+46.2% YoY
Gross margin
47.9%
+2.3 pp YoY
Net income
$207.00M
+47.9% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jul 28, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Jul 28, 2021 · complete as-filed document